Genex Pharmaceutical Inc (GENX)
Genex Pharmaceutical Inc. is a China-based healthcare company listed on OTC Markets under the symbol GENX. Through its common stock, investors are exposed to the operations of an issuer that develops, produces, and distributes Reconstituted Bone Xenograft (RBX), a medical device designed to support and accelerate bone healing. The company’s products are distributed in the People’s Republic of China, with a customer base that includes about 500 hospitals and other medical device customers. Founded in 2003, Genex Pharmaceutical is headquartered in Tianjin, China.
Stock Summary
Fair Value
Profitability & Growth
Quality & Risk
Events & Dividends
Technical Outlook
FAQ
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-GENX
|
—
|
—
|
—
|
—
|
—
|
—
|
Fair
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
1.784 K
|
—
|
—
|
—
|
—
|
—
|
—
|
